The DOI matches its Crossref record; 417 of the 417 references it cites were found in a registry or an index.
Drug allergy: A 2022 practice parameter update
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw118 · Cited by 3,061
McLaughlin, P., Grillo-López, A. J., Link, B. K., Levy, R., Czuczman, M. S., Williams, M. E., Heyman, M. R., Bence-Bruckler, I., White, C. A., Cabanillas, F., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2825 · Cited by 2,755
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308
Self-citationTRY plant trait database – enhanced coverage and open access
Kattge, J., Bönisch, G., Díaz, S., Lavorel, S., Prentice, I. C., Leadley, P., Tautenhahn, S., Werner, G. D. A., Aakala, T., Abedi, M., et al. (2020) · Global Change Biology · doi:10.1111/gcb.14904 · Cited by 2,089
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Mallal, S., Phillips, E., Carosi, G., Molina, J.-M., Workman, C., Tomažič, J., Jägel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706135 · Cited by 1,835
Self-citationA marker for Stevens–Johnson syndrome
Chung, W.-H., Hung, S.-I., Hong, H.-S., Hsih, M.-S., Yang, L.-C., Ho, H.-C., Wu, J.-Y., & Chen, Y.-T. (2004) · Nature · doi:10.1038/428486a · Cited by 1,753
Maloney, D. G., Grillo-López, A. J., White, C. A., Bodkin, D., Schilder, R. J., Neidhart, J. A., Janakiraman, N., Foon, K. A., Liles, T.-M., Dallaire, B. K., et al. (1997) · Blood · doi:10.1182/blood.v90.6.2188 · Cited by 1,733
Bastuji‐Garin, S. (1993) · Archives of Dermatology · doi:10.1001/archderm.129.1.92 · Cited by 1,697
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074943 · Cited by 1,521
Research works printed but not linked: 176
- Khan, 2012, Cutaneous drug reactions, J Allergy Clin Immunol, 130, 1225, 10.1016/j.jaci.2012.08.007 · doi:10.1016/j.jaci.2012.08.007
- Barbaud, 2020, Intradermal tests with drugs: an approach to standardization, Front Med, 7, 156, 10.3389/fmed.2020.00156 · doi:10.3389/fmed.2020.00156
- Blumenthal, 2018, Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study, BMJ, 361
- Blumenthal, 2019, Recorded penicillin allergy and risk of mortality: a population-based matched cohort study, J Gen Intern Med, 34, 1685, 10.1007/s11606-019-04991-y · doi:10.1007/s11606-019-04991-y
- García Rodríguez, 2019, Provocation tests in nonimmediate hypersensitivity reactions to β-lactam antibiotics in children: are extended challenges needed?, J Allergy Clin Immunol Pract, 7, 265, 10.1016/j.jaip.2018.06.023 · doi:10.1016/j.jaip.2018.06.023
- Gallardo, 2020, Sensitization phenotypes in immediate reactions to piperacillin-tazobactam, J Allergy Clin Immunol Pract, 8, 3175, 10.1016/j.jaip.2020.04.008 · doi:10.1016/j.jaip.2020.04.008
- Doña, 2020, Clinical characterization and diagnostic approaches for patients reporting hypersensitivity reactions to quinolones, J Allergy Clin Immunol Pract, 8, 2707, 10.1016/j.jaip.2020.04.051 · doi:10.1016/j.jaip.2020.04.051
- Cavkaytar, 2016, Testing for clarithromycin hypersensitivity: a diagnostic challenge in childhood, J Allergy Clin Immunol Pract, 4, 10.1016/j.jaip.2015.09.015 · doi:10.1016/j.jaip.2015.09.015
- Sala-Cunill, 2021, One-dilution rapid desensitization protocol to chemotherapeutic and biological agents: a five-year experience, J Allergy Clin Immunol Pract, 9, 4045, 10.1016/j.jaip.2021.06.024 · doi:10.1016/j.jaip.2021.06.024
- Weiss, 1992, Hypersensitivity reactions, Semin Oncol, 19, 458
- Trudeau, 1996, Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group, J Clin Oncol, 14, 422, 10.1200/JCO.1996.14.2.422 · doi:10.1200/jco.1996.14.2.422
- Sánchez-López, 2015, Successful oral desensitization in a patient with hypersensitivity reaction to crizotinib, J Investig Allergol Clin Immunol, 25, 307
- Madrigal-Burgaleta, 2019, A large single-hospital experience using drug provocation testing and rapid drug desensitization in hypersensitivity to antineoplastic and biological agents, J Allergy Clin Immunol Pract, 7, 618, 10.1016/j.jaip.2018.07.031 · doi:10.1016/j.jaip.2018.07.031
- Lehloenya, 2011, Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions, Int J Tuberc Lung Dis, 15, 1649, 10.5588/ijtld.10.0698 · doi:10.5588/ijtld.10.0698
- Karmacharya, 2015, Rituximab-induced serum sickness: a systematic review, Semin Arthritis Rheum, 45, 334, 10.1016/j.semarthrit.2015.06.014 · doi:10.1016/j.semarthrit.2015.06.014
- Foong, 2016, Lack of uniformity in the investigation and management of suspected beta-lactam allergy in children, Pediatr Allergy Immunol, 27, 527, 10.1111/pai.12557 · doi:10.1111/pai.12557
- Picard, 2014, A new humanized in vitro model of IgE-mediated rapid desensitization, Clin Transl Allergy, 4, O10, 10.1186/2045-7022-4-S3-O10 · doi:10.1186/2045-7022-4-s3-o10
- Chiriac, 2017, Optimal step doses for drug provocation tests to prove beta-lactam hypersensitivity, Allergy, 72, 552, 10.1111/all.13037 · doi:10.1111/all.13037
- Ozturk, 2013, Determining safe alternatives for multidrug hypersensitive patients with the alternative triple antibiotic-analgesic test, Allergol Immunopathol (Madr), 41, 189, 10.1016/j.aller.2012.01.007 · doi:10.1016/j.aller.2012.01.007
- Guvenir, 2016, Proven non-beta-lactam antibiotic allergy in children, Int Arch Allergy Immunol, 169, 45, 10.1159/000443830 · doi:10.1159/000443830
- Zambonino, 2014, Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children, Pediatr Allergy Immunol, 25, 80, 10.1111/pai.12155 · doi:10.1111/pai.12155
- Vezir, 2014, The evaluation of drug provocation tests in pediatric allergy clinic: a single center experience, Allergy Asthma Proc, 35, 156, 10.2500/aap.2014.35.3744 · doi:10.2500/aap.2014.35.3744
- Indradat, 2016, Provocation proven drug allergy in Thai children with adverse drug reactions, Asian Pac J Allergy Immunol, 34, 59
- Sompornrattanaphan, 2020, Fatal anaphylaxis from a second amoxicillin/clavulanic acid provocation after a prior negative provocation, J Allergy Clin Immunol Pract, 8, 752, 10.1016/j.jaip.2019.07.022 · doi:10.1016/j.jaip.2019.07.022
- Putterman, 1990, "Treating through" hypersensitivity to co-trimoxazole in AIDS patients, Lancet, 336, 52, 10.1016/0140-6736(90)91563-P · doi:10.1016/0140-6736(90)91563-p
- Trautmann, 2017, "Treating through" decision and follow-up in antibiotic therapy-associated exanthemas, J Allergy Clin Immunol Pract, 5, 1650, 10.1016/j.jaip.2017.03.032 · doi:10.1016/j.jaip.2017.03.032
- Trubiano, 2021, Treating through drug-associated exanthems in drug allergy management: current evidence and clinical aspects, J Allergy Clin Immunol Pract, 9, 2984, 10.1016/j.jaip.2021.04.008 · doi:10.1016/j.jaip.2021.04.008
- Lehloenya, 2015, Lack of cross-toxicity between isoniazid and ethionamide in severe cutaneous adverse drug reactions: a series of 25 consecutive confirmed cases, J Antimicrob Chemother, 70, 2648, 10.1093/jac/dkv158 · doi:10.1093/jac/dkv158
- Garcia-Neuer, 2018, Drug-induced paradoxical vocal fold motion, J Allergy Clin Immunol Pract, 6, 90, 10.1016/j.jaip.2017.08.020 · doi:10.1016/j.jaip.2017.08.020
- Raley, 2020, Drug-associated inducible laryngeal obstruction complicating penicillin allergy testing, Ann Allergy Asthma Immunol, 125, 599, 10.1016/j.anai.2020.06.031 · doi:10.1016/j.anai.2020.06.031
- Phillips, 2019, Controversies in drug allergy: testing for delayed reactions, J Allergy Clin Immunol, 143, 66, 10.1016/j.jaci.2018.10.030 · doi:10.1016/j.jaci.2018.10.030
- Barbaud, 2014, Skin testing and patch testing in non-IgE-mediated drug allergy, Curr Allergy Asthma Rep, 14, 442, 10.1007/s11882-014-0442-8 · doi:10.1007/s11882-014-0442-8
- Alvarez-Arango, 2021, Vancomycin immediate skin responses in vancomycin-naïve subjects, Clin Exp Allergy, 51, 932, 10.1111/cea.13850 · doi:10.1111/cea.13850
- Klaewsongkram, 2019, Analysis of HLA-B allelic variation and IFN-gamma ELISpot responses in patients with severe cutaneous adverse reactions associated with drugs, J Allergy Clin Immunol Pract, 7, 219, 10.1016/j.jaip.2018.05.004 · doi:10.1016/j.jaip.2018.05.004
- Suthumchai, 2018, The measurement of drug-induced interferon gamma-releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions, J Eur Acad Dermatol Venereol, 32, 992, 10.1111/jdv.14890 · doi:10.1111/jdv.14890
- Trubiano, 2017, Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis, J Allergy Clin Immunol Pract, 5, 823, 10.1016/j.jaip.2016.09.043 · doi:10.1016/j.jaip.2016.09.043
- Fernandez, 2015, Genome-wide analysis links NFATC2 with asparaginase hypersensitivity, Blood, 126, 69, 10.1182/blood-2015-02-628800 · doi:10.1182/blood-2015-02-628800
- Khan, 2020, Pharmacogenomic biomarkers in allergy and immunology practice, J Allergy Clin Immunol, 146, 509, 10.1016/j.jaci.2020.05.050 · doi:10.1016/j.jaci.2020.05.050
- Macy, 2011, Reply. J Allergy Clin Immunol, 128, 686, 10.1016/j.jaci.2011.04.055 · doi:10.1016/j.jaci.2011.04.055
- Levine, 1967, Prediction of penicillin allergy by immunological tests, Ann N Y Acad Sci, 145, 298, 10.1111/j.1749-6632.1967.tb50227.x · doi:10.1111/j.1749-6632.1967.tb50227.x
- Ibia, 2000, Antibiotic rashes in children: a survey in a private practice setting, Arch Dermatol, 136, 849, 10.1001/archderm.136.7.849 · doi:10.1001/archderm.136.7.849
- Kerns, 1973, Ampicillin rash in children: relationship to penicillin allergy and infectious mononucleosis, Am J Dis Child, 125, 187, 10.1001/archpedi.1973.04160020023004 · doi:10.1001/archpedi.1973.04160020023004
- Patel, 1967, Skin rash with infectious mononucleosis and ampicillin, Pediatrics, 40, 910, 10.1542/peds.40.5.910 · doi:10.1542/peds.40.5.910
- Zhang, 2019, Drug-induced severe cutaneous adverse reactions: determine the cause and prevention, Ann Allergy Asthma Immunol, 123, 483, 10.1016/j.anai.2019.08.004 · doi:10.1016/j.anai.2019.08.004
- Marcos Bravo, 1995, Hypersensitivity to cefuroxime with good tolerance to other betalactams, Allergy, 50, 359, 10.1111/j.1398-9995.1995.tb01160.x · doi:10.1111/j.1398-9995.1995.tb01160.x
- Poston, 2004, Cefazolin tolerance does not predict ceftriaxone hypersensitivity: unique side chains precipitate anaphylaxis, Pharmacotherapy, 24, 668, 10.1592/phco.24.6.668.34753 · doi:10.1592/phco.24.6.668.34753
- Testi, 2010, Nonirritating concentration for skin testing with cephalosporins, J Investig Allergol Clin Immunol, 20, 171
- Koo, 2022, Retrospective stratification of cephalosporin allergy label risk using validated penicillin allergy frameworks, J Allergy Clin Immunol Pract, 10, 2472, 10.1016/j.jaip.2022.05.032 · doi:10.1016/j.jaip.2022.05.032
- Pedersen-Bjergaard, 1967, Cephalothin in the treatment of penicillin sensitive patients, Acta Allergol, 22, 299, 10.1111/j.1398-9995.1967.tb03226.x · doi:10.1111/j.1398-9995.1967.tb03226.x
- Shepherd, 1993, Administration of cephalosporin antibiotics to patients with a history of penicillin allergy, J Allergy Clin Immunol Pract, 91, 262
- Chiron, 2020, Allergy to third- and second-generation cephalosporins in confirmed penicillin-allergic patients, J Allergy Clin Immunol Pract, 8, 2409, 10.1016/j.jaip.2020.03.021 · doi:10.1016/j.jaip.2020.03.021
- Li, 2019, Cross-reactivity to penicillins in cephalosporin anaphylaxis, Br J Anaesth, 123, e532, 10.1016/j.bja.2019.09.011 · doi:10.1016/j.bja.2019.09.011
- Sodhi, 2004, Is it safe to use carbapenems in patients with a history of allergy to penicillin?, J Antimicrob Chemother, 54, 1155, 10.1093/jac/dkh454 · doi:10.1093/jac/dkh454
- Prescott, 2004, Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy, Clin Infect Dis, 38, 1102, 10.1086/382880 · doi:10.1086/382880
- McConnell, 2000, Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy, Clin Infect Dis, 31, 1512, 10.1086/317507 · doi:10.1086/317507
- Sanchez-Borges, 2001, Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions, Ann Allergy Asthma Immunol, 87, 201, 10.1016/S1081-1206(10)62226-0 · doi:10.1016/s1081-1206(10)62226-0
- Kula, 2014, A systematic review: can one prescribe carbapenems to patients with IgE-mediated allergy to penicillins or cephalosporins?, Clin Infect Dis, 59, 1113, 10.1093/cid/ciu587 · doi:10.1093/cid/ciu587
- Adkinson, 1990, Immunogenicity and cross-allergenicity of aztreonam, Am J Med, 88, S3
- Saxon, 1985, Investigation into the immunologic cross-reactivity of aztreonam with other beta-lactam antibiotics, Am J Med, 78, 19, 10.1016/0002-9343(85)90198-6 · doi:10.1016/0002-9343(85)90198-6
- Graninger, 1985, Aztreonam efficacy in difficult-to-treat infections and tolerance in patients with beta-lactam hypersensitivity, Chemioterapia, 4, 64
- Adkinson, 1984, Immunology of the monobactam aztreonam, Antimicrob Agents Chemother, 25, 93, 10.1128/AAC.25.1.93 · doi:10.1128/aac.25.1.93
- Adkinson, 1985, Cross-allergenicity and immunogenicity of aztreonam, Rev Infect Dis, 7, S613, 10.1093/clinids/7.Supplement_4.S613 · doi:10.1093/clinids/7.supplement_4.s613
- Vaisman, 2017, Clarifying a "penicillin" allergy: a teachable moment, JAMA Intern Med, 177, 269, 10.1001/jamainternmed.2016.8185 · doi:10.1001/jamainternmed.2016.8185
- Belchi-Hernandez, 1996, Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection, Ann Allergy Asthma Immunol, 76, 355, 10.1016/S1081-1206(10)60037-3 · doi:10.1016/s1081-1206(10)60037-3
- Ozkaya-Bayazit, 1999, Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption, Contact Dermatitis, 41, 185, 10.1111/j.1600-0536.1999.tb06127.x · doi:10.1111/j.1600-0536.1999.tb06127.x
- Bonfanti, 2000, The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. CISAI Group, Biomed Pharmacother, 54, 45, 10.1016/S0753-3322(00)88640-0 · doi:10.1016/s0753-3322(00)88640-0
- Straatmann, 2002, A randomized, pilot trial comparing full versus escalating dose regimens for the desensitization of AIDS patients allergic to sulfonamides, Braz J Infect Dis, 6, 276, 10.1590/S1413-86702002000600002 · doi:10.1590/s1413-86702002000600002
- Leoung, 2001, Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ, J Infect Dis, 184, 992, 10.1086/323353 · doi:10.1086/323353
- Gluckstein, 1995, Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ, Clin Infect Dis, 20, 849, 10.1093/clinids/20.4.849 · doi:10.1093/clinids/20.4.849
- Hughes, 1986, Co-trimoxazole desensitization in bone marrow transplantation, Ann Intern Med, 105, 148, 10.7326/0003-4819-105-1-148 · doi:10.7326/0003-4819-105-1-148
- Soffritti, 2003, Successful desensitization to trimethoprim-sulfamethoxazole after allogeneic haematopoietic stem cell transplantation: preliminary observations, Med Pediatr Oncol, 40, 271, 10.1002/mpo.10196 · doi:10.1002/mpo.10196
- Krantz, 2021, Reply to “The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy”, J Allergy Clin Immunol Pract, 9, 3849, 10.1016/j.jaip.2021.07.027 · doi:10.1016/j.jaip.2021.07.027
- Ball, 2004, A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context, Int J Antimicrob Agents, 23, 421, 10.1016/j.ijantimicag.2004.02.014 · doi:10.1016/j.ijantimicag.2004.02.014
- Manfredi, 2004, Detection of specific IgE to quinolones, J Allergy Clin Immunol, 113, 155, 10.1016/j.jaci.2003.09.035 · doi:10.1016/j.jaci.2003.09.035
- Venturini Diaz, 2017, In vivo diagnostic tests in adverse reactions to quinolones, J Investig Allergol Clin Immunol, 17, 393
- Anovadiya, 2011, Cross sensitivity between ciprofloxacin and levofloxacin for an immediate hypersensitivity reaction, J Pharmacol Pharmacother, 2, 187, 10.4103/0976-500X.83285 · doi:10.4103/0976-500x.83285
- Davila, 1993, Cross-reactivity between quinolones: report of three cases, Allergy, 48, 388, 10.1111/j.1398-9995.1993.tb02413.x · doi:10.1111/j.1398-9995.1993.tb02413.x
- Gonzalez-Mancebo, 2004, Immediate hypersensitivity to levofloxacin diagnosed through skin prick test, Ann Pharmacother, 38, 354, 10.1345/aph.1D159 · doi:10.1345/aph.1d159
- Lobera, 2010, Allergy to quinolones: low cross-reactivity to levofloxacin, J Investig Allergol Clin Immunol, 20, 607
- Sanchez-Morillas, 2010, Systemic anaphylaxis caused by moxifloxacin, Allergol Immunopathol (Madr), 38, 226, 10.1016/j.aller.2009.09.008 · doi:10.1016/j.aller.2009.09.008
- Demir, 2017, Usefulness of in vivo and in vitro diagnostic tests in the diagnosis of hypersensitivity reactions to quinolones and in the evaluation of cross-reactivity: a comprehensive study including the latest quinolone gemifloxacin, Allergy Asthma Immunol Res, 9, 347, 10.4168/aair.2017.9.4.347 · doi:10.4168/aair.2017.9.4.347
- Gea-Banacloche, 1996, Ciprofloxacin desensitization, J Allergy Clin Immunol, 97, 1426, 10.1016/S0091-6749(96)70218-X · doi:10.1016/s0091-6749(96)70218-x
- Lantner, 1995, Ciprofloxacin desensitization in a patient with cystic fibrosis, J Allergy Clin Immunol, 96, 1001, 10.1016/S0091-6749(95)70240-7 · doi:10.1016/s0091-6749(95)70240-7
- Treadway, 1996, Paediatric safety of azithromycin: worldwide experience, J Antimicrob Chemother, 37, 143, 10.1093/jac/37.suppl_C.143 · doi:10.1093/jac/37.suppl_c.143
- van der Linden, 1998, Skin reactions to antibacterial agents in general practice, J Clin Epidemiol, 51, 703, 10.1016/S0895-4356(98)00041-9 · doi:10.1016/s0895-4356(98)00041-9
- Benahmed, 2004, The accuracy of the diagnosis of suspected macrolide antibiotic hypersensitivity: results of a single-blinded trial, Allergy, 59, 1130, 10.1111/j.1398-9995.2004.00638.x · doi:10.1111/j.1398-9995.2004.00638.x
- Lammintausta, 2005, Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period, Acta Derm Venereol, 85, 491, 10.1080/00015550510042859 · doi:10.1080/00015550510042859
- Mori, 2010, Sensitivity and specificity of skin tests in the diagnosis of clarithromycin allergy, Ann Allergy Asthma Immunol, 104, 417, 10.1016/j.anai.2010.03.010 · doi:10.1016/j.anai.2010.03.010
- Laurie, 2000, Successful clarithromycin desensitization in a macrolide-sensitive patient (abstract), Ann Allergy Asthma Immunol, 84, 116
- Asero, 2005, Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs, Clin Exp Allergy, 35, 713, 10.1111/j.1365-2222.2005.2228.x · doi:10.1111/j.1365-2222.2005.2228.x
- Asero, 2006, Use of ketoprofen oral challenges to detect cross-reactors among patients with a history of aspirin-induced urticaria, Ann Allergy Asthma Immunol, 97, 187, 10.1016/S1081-1206(10)60011-7 · doi:10.1016/s1081-1206(10)60011-7
- Kim, 2007, The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery, Ear Nose Throat J, 86, 396, 10.1177/014556130708600715 · doi:10.1177/014556130708600715
- Dursun, 2008, Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis, Ann Allergy Asthma Immunol, 100, 420, 10.1016/S1081-1206(10)60465-6 · doi:10.1016/s1081-1206(10)60465-6
- Cook, 2017, Use of a composite symptom score during challenge in patients with suspected aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 118, 597, 10.1016/j.anai.2017.02.016 · doi:10.1016/j.anai.2017.02.016
- Staso, 2021, Scoring tool for systemic symptoms during aspirin challenge detects mediator production in aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 127, 131, 10.1016/j.anai.2021.03.025 · doi:10.1016/j.anai.2021.03.025
- White, 2013, The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease, Allergy Asthma Proc, 34, 378, 10.2500/aap.2013.34.3670 · doi:10.2500/aap.2013.34.3670
- Lang, 2018, Omalizumab can inhibit respiratory reaction during aspirin desensitization, Ann Allergy Asthma Immunol, 121, 98, 10.1016/j.anai.2018.05.007 · doi:10.1016/j.anai.2018.05.007
- Huang, 2019, Sinus surgery improves lower respiratory tract reactivity during aspirin desensitization for AERD, J Allergy Clin Immunol Pract, 7, 1647, 10.1016/j.jaip.2019.02.037 · doi:10.1016/j.jaip.2019.02.037
- Chen, 2015, An hourly dose-escalation desensitization protocol for aspirin-exacerbated respiratory disease, J Allergy Clin Immunol Pract, 3, 926, 10.1016/j.jaip.2015.06.013 · doi:10.1016/j.jaip.2015.06.013
- Lee, 2010, Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 105, 130, 10.1016/j.anai.2010.05.020 · doi:10.1016/j.anai.2010.05.020
- DeGregorio, 2019, A 1-day, 90-minute aspirin challenge and desensitization protocol in aspirin-exacerbated respiratory disease, J Allergy Clin Immunol Pract, 7, 1174, 10.1016/j.jaip.2018.10.032 · doi:10.1016/j.jaip.2018.10.032
- Pelletier, 2019, Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease, J Allergy Clin Immunol Pract, 7, 1319, 10.1016/j.jaip.2018.08.004 · doi:10.1016/j.jaip.2018.08.004
- Pleskow, 1982, Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period, J Allergy Clin Immunol, 69, 11, 10.1016/0091-6749(82)90081-1 · doi:10.1016/0091-6749(82)90081-1
- Wangberg, 2021, Perioperative management and perceived risks of sinus surgery in patients with aspirin-exacerbated respiratory disease, Int Forum Allergy Rhinol, 11, 1132, 10.1002/alr.22789 · doi:10.1002/alr.22789
- Do, 2019, Long-term assessment of aspirin desensitization shows successful bridging with non-aspirin nonsteroidal anti-inflammatory drugs for procedures, Allergy Asthma Proc, 40, 311, 10.2500/aap.2019.40.4239 · doi:10.2500/aap.2019.40.4239
- White, 2005, The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease, Ann Allergy Asthma Immunol, 95, 330, 10.1016/S1081-1206(10)61150-7 · doi:10.1016/s1081-1206(10)61150-7
- White, 2006, Effect of leukotriene modifier drugs on the safety of oral aspirin challenges, Ann Allergy Asthma Immunol, 97, 688, 10.1016/S1081-1206(10)61101-5 · doi:10.1016/s1081-1206(10)61101-5
- Kowalski, 1986, Clinical efficacy of aspirin in "desensitised" aspirin-sensitive asthmatics, Eur J Respir Dis, 69, 219
- Cho, 2014, Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease, Otolaryngol Head Neck Surg, 151, 575, 10.1177/0194599814545750 · doi:10.1177/0194599814545750
- Sánchez-Borges, 2015, Aspirin-exacerbated cutaneous disease (AECD) is a distinct subphenotype of chronic spontaneous urticaria, J Eur Acad Dermatol Venereol, 29, 698, 10.1111/jdv.12658 · doi:10.1111/jdv.12658
- Asero, 2002, Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs, Ann Allergy Asthma Immunol, 88, 468, 10.1016/S1081-1206(10)62384-8 · doi:10.1016/s1081-1206(10)62384-8
- Asero, 2003, Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria, J Allergy Clin Immunol, 111, 1095, 10.1067/mai.2003.1444 · doi:10.1067/mai.2003.1444
- Perrone, 2003, Tolerability of rofecoxib in patients with adverse reactions to nonsteroidal anti-inflammatory drugs: a study of 216 patients and literature review, Int Arch Allergy Immunol, 132, 82, 10.1159/000073268 · doi:10.1159/000073268
- Nettis, 2002, Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs, Ann Allergy Asthma Immunol, 88, 331, 10.1016/S1081-1206(10)62017-0 · doi:10.1016/s1081-1206(10)62017-0
- Sánchez, 2020, Clinical control of CSU with antihistamines allows for tolerance of NSAID-exacerbated cutaneous disease, J Allergy Clin Immunol Pract, 8, 3577, 10.1016/j.jaip.2020.06.057 · doi:10.1016/j.jaip.2020.06.057
- Walters, 2016, Tolerance to nonsteroidal anti-inflammatory drugs and alcohol after omalizumab treatment in a patient with chronic urticaria, Ann Allergy Asthma Immunol, 117, 559, 10.1016/j.anai.2016.08.020 · doi:10.1016/j.anai.2016.08.020
- Asero, 2018, Restoration of aspirin tolerance following omalizumab treatment in a patient with chronic spontaneous urticaria, Eur Ann Allergy Clin Immunol, 50, 226, 10.23822/EurAnnACI.1764-1489.36 · doi:10.23822/eurannaci.1764-1489.36
- Doña, 2017, Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria/angioedema, Allergy, 72, 1346, 10.1111/all.13147 · doi:10.1111/all.13147
- Doña, 2014, NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study, Allergy, 69, 438, 10.1111/all.12335 · doi:10.1111/all.12335
- Goksel, 2010, Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema, J Dermatol, 37, 973, 10.1111/j.1346-8138.2010.00948.x · doi:10.1111/j.1346-8138.2010.00948.x
- Rossini, 2008, Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation, Am J Cardiol, 101, 786, 10.1016/j.amjcard.2007.10.045 · doi:10.1016/j.amjcard.2007.10.045
- Silberman, 2005, Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting, Am J Cardiol, 95, 509, 10.1016/j.amjcard.2004.10.022 · doi:10.1016/j.amjcard.2004.10.022
- Moore, 1980, Nonsteroidal anti-inflammatory intolerance. an anaphylactic reaction to tolmetin, Arch Intern Med, 140, 1105, 10.1001/archinte.1980.00330190117037 · doi:10.1001/archinte.1980.00330190117037
- Alkhawajah, 1993, Fatal anaphylactic reaction to diclofenac, Forensic Sci Int, 60, 107, 10.1016/0379-0738(93)90098-U · doi:10.1016/0379-0738(93)90098-u
- Himly, 2003, IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone, J Allergy Clin Immunol, 111, 882, 10.1067/mai.2003.163 · doi:10.1067/mai.2003.163
- Couto, 2012, IgE-mediated metamizol allergy and the usefulness of the cellular allergen stimulation test, Eur Ann Allergy Clin Immunol, 44, 113
- Fontaine, 2005, Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole, J Allergy Clin Immunol, 115, 633, 10.1016/j.jaci.2004.10.045 · doi:10.1016/j.jaci.2004.10.045
- Cortellini, 2017, Clinical approach on challenge and desensitization procedures with aspirin in patients with ischemic heart disease and nonsteroidal anti-inflammatory drug hypersensitivity, Allergy, 72, 498, 10.1111/all.13068 · doi:10.1111/all.13068
- Gendernalik, 2009, Fixed drug eruptions: a case report and review of the literature, Cutis, 84, 215
- Blanca-López, 2018, Acetyl salicylic acid challenge in children with hypersensitivity reactions to nonsteroidal anti-inflammatory drugs differentiates between cross-intolerant and selective responders, J Allergy Clin Immunol Pract, 6, 1226, 10.1016/j.jaip.2017.08.029 · doi:10.1016/j.jaip.2017.08.029
- Mori, 2020, A multicenter retrospective study on hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) in children: a report from the European Network on Drug Allergy (ENDA) Group, J Allergy Clin Immunol Pract, 8, 1022, 10.1016/j.jaip.2019.10.049 · doi:10.1016/j.jaip.2019.10.049
- Cousin, 2016, Phenotypical characterization of children with hypersensitivity reactions to NSAIDs, Pediatr Allergy Immunol, 27, 743, 10.1111/pai.12596 · doi:10.1111/pai.12596
- Camara, 2005, Clopidogrel (Plavix) desensitization: a case series, Catheter Cardiovasc Interv, 65, 525
- Camara, 2007, Clopidogrel (Plavix) desensitization protocol, Catheter Cardiovasc Interv, 69, 154
- Makrilia, 2010, Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review, Met Based Drugs, 2010, 10.1155/2010/207084 · doi:10.1155/2010/207084
- Shibata, 2009, Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan, Int J Clin Oncol, 14, 397, 10.1007/s10147-009-0883-6 · doi:10.1007/s10147-009-0883-6
- Pellegrino, 2017, Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review, Acta Biomed, 88, 329
- Tsao, 2022, Hypersensitivity reactions to platinum agents and taxanes, Clin Rev Allergy Immunol, 62, 432, 10.1007/s12016-021-08877-y · doi:10.1007/s12016-021-08877-y
- Pasteur, 2019, Low cross-reactivity between cisplatin and other platinum salts, J Allergy Clin Immunol Pract, 7, 1894, 10.1016/j.jaip.2019.01.057 · doi:10.1016/j.jaip.2019.01.057
- Sánchez-Muñoz, 2011, Cross-sensitivity between taxanes in patients with breast cancer, Clin Transl Oncol, 13, 904, 10.1007/s12094-011-0753-3 · doi:10.1007/s12094-011-0753-3
- Dizon, 2006, Cross-sensitivity between paclitaxel and docetaxel in a women's cancers program, Gynecol Oncol, 100, 149, 10.1016/j.ygyno.2005.08.004 · doi:10.1016/j.ygyno.2005.08.004
- Koren, 2002, Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancy, Am J Clin Oncol, 25, 625, 10.1097/00000421-200212000-00020 · doi:10.1097/00000421-200212000-00020
- Polyzos, 2009, Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience, Oncology, 76, 36, 10.1159/000178163 · doi:10.1159/000178163
- Syrigou, 2010, Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?, Anticancer Drugs, 21, 333, 10.1097/CAD.0b013e32833418c0 · doi:10.1097/cad.0b013e32833418c0
- Leguy-Seguin, 2007, Diagnostic and predictive value of skin testing in platinum salt hypersensitivity, J Allergy Clin Immunol, 119, 726, 10.1016/j.jaci.2006.11.640 · doi:10.1016/j.jaci.2006.11.640
- Koshiba, 2009, Incidence of Carboplatin-related hypersensitivity reactions in Japanese patients with gynecologic malignancies, Int J Gynecol Cancer, 19, 460, 10.1111/IGC.0b013e3181a1bf2e · doi:10.1111/igc.0b013e3181a1bf2e
- Goldberg, 1996, A modified, prolonged desensitization protocol in carboplatin allergy, J Allergy Clin Immunol, 98, 841, 10.1016/S0091-6749(96)70134-3 · doi:10.1016/s0091-6749(96)70134-3
- Gomez, 2009, Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study, Int J Gynecol Cancer, 19, 1284, 10.1111/IGC.0b013e3181a418ff · doi:10.1111/igc.0b013e3181a418ff
- Levin, 2020, Platin risk stratification algorithm with modified intradermal skin test protocol, J Allergy Clin Immunol Pract, 8, 1139, 10.1016/j.jaip.2019.08.055 · doi:10.1016/j.jaip.2019.08.055
- Chung, 2018, A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity, Cancer Chemother Pharmacol, 82, 777, 10.1007/s00280-018-3662-0 · doi:10.1007/s00280-018-3662-0
- Madrigal-Burgaleta, 2013, Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment, Allergy, 68, 853, 10.1111/all.12105 · doi:10.1111/all.12105
- Alvarez-Cuesta, 2015, Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization, Allergy, 70, 784, 10.1111/all.12620 · doi:10.1111/all.12620
- Otani, 2018, Utility of risk stratification for paclitaxel hypersensitivity reactions, J Allergy Clin Immunol Pract, 6, 1266, 10.1016/j.jaip.2017.08.025 · doi:10.1016/j.jaip.2017.08.025
- De Lira-Quezada, 2018, Early and delayed hypersensitivity reactions to paclitaxel: desensitization as a challenge, Ann Allergy Asthma Immunol, 121, S72, 10.1016/j.anai.2018.09.234 · doi:10.1016/j.anai.2018.09.234
- Horvat, 2016, The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance, Leuk Res, 50, 17, 10.1016/j.leukres.2016.08.014 · doi:10.1016/j.leukres.2016.08.014
- August, 2020, Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma, Pediatr Blood Cancer, 67, 10.1002/pbc.28021 · doi:10.1002/pbc.28021
- Sato, 2020, Osimertinib-associated toxic epidermal necrolysis in a lung cancer patient harboring an EGFR mutation—a case report and a review of the literature, Medicina (Kaunas), 56, 403, 10.3390/medicina56080403 · doi:10.3390/medicina56080403
- Pasadyn, 2020, Cutaneous adverse effects of biologic medications, Cleve Clin J Med, 87, 288, 10.3949/ccjm.87a.19119 · doi:10.3949/ccjm.87a.19119
- Iimura, 2018, NSAIDs may prevent EGFR-TKI-related skin rash in non-small cell lung cancer patients, Int J Clin Pharmacol Ther, 56, 551, 10.5414/CP203323 · doi:10.5414/cp203323
- Makino, 2013, Treatment strategy for reducing the risk of rituximab-induced cytokine release syndrome in patients with intravascular large B-cell lymphoma: a case report and review of the literature, J Med Case Rep, 7, 280, 10.1186/1752-1947-7-280 · doi:10.1186/1752-1947-7-280
- Gold, 2017, Premedication use in preventing acute infliximab infusion reactions in patients with inflammatory bowel disease: a single center cohort study, Inflamm Bowel Dis, 23, 1882, 10.1097/MIB.0000000000001189 · doi:10.1097/mib.0000000000001189
- Rocchi, 2014, Hypersensitivity reactions to tocilizumab: role of skin tests in diagnosis, Rheumatology (Oxford), 53, 1527, 10.1093/rheumatology/keu181 · doi:10.1093/rheumatology/keu181
- Cansever, 2018, Successful slow desensitization to tocilizumab in a 15-year-old patient, J Investig Allergol Clin Immunol, 28, 436, 10.18176/jiaci.0314 · doi:10.18176/jiaci.0314
- Sakaue, 2014, Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis, Rheumatology (Oxford), 53, 1529, 10.1093/rheumatology/keu008 · doi:10.1093/rheumatology/keu008
- Cortellini, 2018, Effective desensitization to tocilizumab in delayed hypersensitivity reaction, Pharmacology, 102, 114, 10.1159/000490419 · doi:10.1159/000490419
- Weiss, 2020, A case of serum sickness-like reaction in an adult treated with omalizumab, Mil Med, 185, e912, 10.1093/milmed/usz357 · doi:10.1093/milmed/usz357
- Jeimy, 2019, Dermatomyositis associated with omalizumab therapy for severe asthma: a case report, Allergy Asthma Clin Immunol, 15, 4, 10.1186/s13223-019-0319-4 · doi:10.1186/s13223-019-0319-4
- Brockow, 2021, "Idiopathic" anaphylaxis caused by carboxymethylcellulose in ice cream, J Allergy Clin Immunol Pract, 9, 555, 10.1016/j.jaip.2020.10.051 · doi:10.1016/j.jaip.2020.10.051
- Klein, 1998, Anaphylaxis from the carboxymethylcellulose component of barium sulfate suspension, N Engl J Med, 338, 623, 10.1056/NEJM199802263380915 · doi:10.1056/nejm199802263380915
- Ohnishi, 2019, Anaphylaxis to carboxymethylcellulose: add food additives to the list of elicitors, Pediatrics, 143, 10.1542/peds.2018-1180 · doi:10.1542/peds.2018-1180
- Bircher, 2004, Oral tolerance of carboxymethylcellulose in patients with anaphylaxis to parenteral carboxymethylcellulose, Ann Allergy Asthma Immunol, 92, 580, 10.1016/S1081-1206(10)61769-3 · doi:10.1016/s1081-1206(10)61769-3
- Garcia-Ortega, 2003, Carboxymethylcellulose allergy as a cause of suspected corticosteroid anaphylaxis, Ann Allergy Asthma Immunol, 91, 421, 10.1016/S1081-1206(10)61698-5 · doi:10.1016/s1081-1206(10)61698-5
- Rutkowski, 2020, Immediate hypersensitivity reactions to steroids and steroid containing medications, Curr Opin Allergy Clin Immunol, 20, 362, 10.1097/ACI.0000000000000655 · doi:10.1097/aci.0000000000000655
- Bonanni, 2021, Anaphylaxis after injecting a hemostatic agent containing gelatin into vertebral bone under pressure-a warning, Spine Deform, 9, 1191, 10.1007/s43390-020-00273-4 · doi:10.1007/s43390-020-00273-4
- Aminsharifi, 2019, Major complications and adverse events related to the injection of the SpaceOAR hydrogel system before radiotherapy for prostate cancer: review of the manufacturer and user facility device experience database, J Endourol, 33, 868, 10.1089/end.2019.0431 · doi:10.1089/end.2019.0431
- Scheman, 2018, Contact allergy to propylene glycol and cross-reactions, Dermatitis, 29, 350, 10.1097/DER.0000000000000416 · doi:10.1097/der.0000000000000416
Cited by
Hardin, H., Shao, W., & Bernstein, J. A. (2023) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2023.08.022 · Cited by 10
Self-citation
Metadata
- Authors
- Khan, D. A., Banerji, A., Blumenthal, K. G., Phillips, E. J., Solensky, R., White, A. A., Bernstein, J. A., Chu, D. K., Ellis, A. K., Golden, D. B. K., Greenhawt, M. J., Horner, C. C., Ledford, D., Lieberman, J. A., Oppenheimer, J., Rank, M. A., Shaker, M. S., Stukus, D. R., Wallace, D., Wang, J., Khan, D. A., Golden, D. B. K., Shaker, M., Stukus, D. R., Khan, D. A., Banerji, A., Blumenthal, K. G., Phillips, E. J., Solensky, R., White, A. A., Bernstein, J. A., Chu, D. K., Ellis, A. K., Golden, D. B. K., Greenhawt, M. J., Horner, C. C., Ledford, D., Lieberman, J. A., Oppenheimer, J., Rank, M. A., Shaker, M. S., Stukus, D. R., Wallace, D., & Wang, J.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 150
- Issue
- 6
- Pages
- 1333-1393
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W4296178925
- Cited by
- 563
- References
- 417
- FWCI
- 48.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 369 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drug allergy: A 2022 practice parameter update. https://app.cochat.ai/papers/10.1016/j.jaci.2022.08.028
- The paper
- Khan, D. A., Banerji, A., Blumenthal, K. G., Phillips, E. J., Solensky, R., White, A. A., Bernstein, J. A., Chu, D. K., Ellis, A. K., Golden, D. B. K., Greenhawt, M. J., Horner, C. C., Ledford, D., Lieberman, J. A., Oppenheimer, J., Rank, M. A., Shaker, M. S., Stukus, D. R., Wallace, D., . . . Wang, J. (2022). Drug allergy: A 2022 practice parameter update. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2022.08.028
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.